Abstract

CRISPR/Cas9 genome editing has revolutionized functional genomics in vertebrates. However, CRISPR/Cas9 edited F0 animals too often demonstrate variable phenotypic penetrance due to the mosaic nature of editing outcomes after double strand break (DSB) repair. Even with high efficiency levels of genome editing, phenotypes may be obscured by proportional presence of in-frame mutations that still produce functional protein. Recently, studies in cell culture systems have shown that the nature of CRISPR/Cas9-mediated mutations can be dependent on local sequence context and can be predicted by computational methods. Here, we demonstrate that similar approaches can be used to forecast CRISPR/Cas9 gene editing outcomes in Xenopus tropicalis, Xenopus laevis, and zebrafish. We show that a publicly available neural network previously trained in mouse embryonic stem cell cultures (InDelphi-mESC) is able to accurately predict CRISPR/Cas9 gene editing outcomes in early vertebrate embryos. Our observations can have direct implications for experiment design, allowing the selection of guide RNAs with predicted repair outcome signatures enriched towards frameshift mutations, allowing maximization of CRISPR/Cas9 phenotype penetrance in the F0 generation.

Details

Title
Maximizing CRISPR/Cas9 phenotype penetrance applying predictive modeling of editing outcomes in Xenopus and zebrafish embryos
Author
Naert, Thomas 1 ; Tulkens Dieter 1 ; Edwards, Nicole A 2 ; Carron Marjolein 3 ; Nikko-Ideen, Shaidani 4 ; Wlizla Marcin 4 ; Annekatrien, Boel 5 ; Demuynck Suzan 1 ; Horb, Marko E 4 ; Coucke, Paul 5 ; Willaert, Andy 5 ; Zorn, Aaron M 2 ; Vleminckx Kris 6 

 Ghent University, Department of Biomedical Molecular Biology, Ghent (Zwijnaarde), Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Cancer Research Institute Ghent, Ghent, Belgium (GRID:grid.5342.0) 
 Cincinnati Children’s Hospital, Division of Developmental Biology, Perinatal Institute, and Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099) 
 Ghent University, Department of Biomedical Molecular Biology, Ghent (Zwijnaarde), Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Ghent University, Center for Medical Genetics, Department of Biomolecular Medicine, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
 Marine Biological Laboratory, National Xenopus Resource and Eugene Bell Center for Regenerative Biology and Tissue Engineering, Woods Hole, USA (GRID:grid.144532.5) (ISNI:000000012169920X) 
 Ghent University, Center for Medical Genetics, Department of Biomolecular Medicine, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
 Ghent University, Department of Biomedical Molecular Biology, Ghent (Zwijnaarde), Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Cancer Research Institute Ghent, Ghent, Belgium (GRID:grid.5342.0); Ghent University, Center for Medical Genetics, Department of Biomolecular Medicine, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1893963245
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.